The EUCAST breakpoint tables are part of a system for categorising microorganisms as susceptible (S and I) and resistant (R) to agents approved for use in the treatment of infectious diseases. Breakpoint tables are freely available but we would like to remind users of other parts of the system which…
Get to know moreProposed revision of breakpoints for trimethoprim-sulfamethoxazole and trimethoprim - public consultation 2025-05-07 - 2025-06-18. The current breakpoints of trimethoprim-sulfamethoxazole are higher than the epidemiological cut-off values for several species. There is absence of PK/PD data for…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs The EUCAST AMST develops breakpoints and methods for antimicrobial susceptibility testing of mycobacteria. Rationale Documents Discover More Public Consultations A chance to review proposed EUCAST changes. Discover More Submit non-truncated MIC…
Get to know moreEUCAST Statutes EUCAST Statutes outlines the objectives, membership structure, consultation and decision process, breakpoint setting for new agents, meetings, publication policy, declarations of interests and funding of EUCAST. The statutes were originally published in November 1999 and have been…
Get to know moreEUCAST general and public consultation on breakpoints for anaerobic bacteria. Theconsultation pertains to the clinical breakpoints for Bacteroides spp., Prevotella spp., Fusobacterium necrophorum, Clostridium perfringens and Cutibacterium acnes that have now been reviewed against the MIC and zone…
Get to know moreFluoroquinolone breakpoints are under review. Shortly there will be a public consultation. Since industry and users sometimes complain that EUCAST fails to warn of upcoming changes we now emphasize that (a) a change is coming, (b) breakpoints will be reduced further and that (c) screening for…
Get to know moreSubcommittees EUCAST subcommittees are set up to deal with specific issues or areas requiring particular expertise. Consultations and decisions on subcommittee proposals are made through the EUCAST Steering Committee and follows the structure of all other consultations and decisions. When…
Get to know moreImportant Additional Information Expected phenotypes, expert rules, and detection of resistance mechanisms are important complements to susceptibility testing and should be consulted before releasing results. Expected phenotypes help with validation of identification and susceptibility tests. Expert…
Get to know moreThere are several public consultations which will expire 15 November, 2021. Vibrio species - genral consultationon EUCAST clinical breakpoints for five species pathogenic to man(1 October - 15 November). Queries on the material can be addressed to G Kahlmeter (gunnar.kahlmeter@eucast.org)…
Get to know moreAbout The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is a scientific committee formed in 1997. EUCAST is jointly organised by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), the European Centre for Disease Prevention and Control (ECDC), and…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.